VARYTEX builds a suite of products centered on its "Kampo diagnostic support software," a SaMD-targeted program and related non-medical tools designed to help physicians use Kampo medicine appropriately and safely. The company is developing both clinician-facing decision support and research tools in collaboration with the Japanese Society of Oriental Medicine to collect clinical data and validate Kampo efficacy. Its products aim to assist non-specialist physicians, support Kampo specialists' workflows, and enable rapid AI-driven analysis of accumulated clinical data. VARYTEX has been iterating its product with university hospitals and obstetrics clinics and plans ongoing UI/UX and product-performance improvements. It also plans to formally launch the non-medical device "KAMPO365works" at the end of May as a precursor to medical-device approval. The company reports cumulative fundraising of ¥210M and completed a pre-Series A fundraising round to accelerate regulatory, clinical, and product efforts.

Total raised

$1M

Funding rounds

1

Latest round

Series A

Latest activity

Apr 2024